Financials
- Fiscal year
- 2025
- Total assets
- €4,686
- Loss
- -€2,403
- Solvency
- 12.7%
B-Pharma Consulting
ActiveSummary
B-Pharma Consulting is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The annual accounts of B-Pharma Consulting for fiscal year 2025 show a net loss of 51% of total assets. The 2025 annual accounts show equity of €597 and a net result of -€2,403. Its solvency ranks better than 21% of 8997 sector peers (fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
Activity
Other business support services
NACE 82990
1 site
Size
€4,686total assets 2025
- Equity
- €597
- Loss
- -€2,403
Turnover not published (abridged schema)
Structure
Accounts 1 d early0 of 1 deed read
Why 30- Weak solvency vs sector- Young companyLatest accounts filed on timeShow the evidence
Checked score
Score 2025
30
/ 100
Weak
Without a bankruptcy probability: score from the figures alone
Financial strength
Weak
Solvency
38
equity 12.7% of total assets
Liquidity
52
short-term debt 87.3% · cash 64.1%
Profitability
0
return on assets -51.3%
Bankruptcy probability, 12 months
This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.
No publishable credit limit; credit only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
balance sheet total too small for a liquidity verdict.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 8997 sector peers (2025).
NBB · sector comparisonPosition among 8997 sector peers
Solvency
better than 21%
← weakest
strongest →
raises risk · Young company
Founded in 2025, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
1 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
- Annual accounts filedfiscal year 2025 · micro…
Key points
By topic
Timeline
- Events
- 1
- Since
- 2026
- 30-07-2026Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Other business support servicesNACE 82990
- Founded
- 05-12-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.